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DEBATE ARTICLE
Electron beam computed tomography with
suspected CAD: the preferred initial
diagnostic test in clinically stable patients
C.A. Geluk, F. Zijlstra
The presence ofcoronary atherosclerosis in clinically
stable patients with suspected coronary artery
disease (CAD) is initially evaluated by clinical, ECG and
laboratory characteristics. In Europe and the Nether-
lands, the exercise tolerance test was traditionally the
first choice of additional testing in these patients. In
the last decade, a promising new noninvasive imaging
modality has been developed, namely electron beam
computed tomography (EBCT). EBCT is a quick and
noninvasive procedure requiring less than five minutes
ofscan time and with a low dose ofradiation exposure
(<1.0 mSv). EBCT detects coronary calcifications and
may represent a superior first-line diagnostic tool in
the evaluation ofsuspected CAD.'We will explain the
rationale ofEBCT as a first-line diagnostic tool in the
evaluation of suspected CAD. Pathophysiological as
well as clinical arguments support the concept that
EBCT is superior to exercise tolerance testing as initial
diagnostic test.
The first question to be answered is how the
current concepts ofdiagnostic tests are related to the
pathophysiological atherosclerotic process. Coronary
atherosclerosis results from a consecutive process of
endothelial dysfunction, development of fatty streaks
(type I-III plaque according toAHA/ACC criteria I-
VI) and of atheroma including a lipid core (type IV
plaque) and fibrotic and/or calcified tissue (type V
plaque). Coronary calcifications are 100% specific for
the atherosclerotic process. Although the precise
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mechanism ofcalcium deposition is still unclear, it has
been shown that matrix glycoproteins play a part in
this process. The amount of coronary calcification is
correlated with total plaque volume in autopsied
hearts.2 In addition, amounts ofcoronary calcifications
detected by EBCT are associated with the presence of
obstructive CAD at coronary angiography.3 Both type
IV and V plaques are prone to rupture (resulting in a
type VI plaque) and may result in an acute coronary
syndrome. In these consecutive processes (I-VI),
narrowing of the coronary luminal diameter occurs
only in the later stages, since the first stages of the
atherosclerotic process are associated with positive
remodelling. Noninvasive stress tests evaluate whether
myocardial ischaemia occurs with increasing myo-
cardial oxygen demands in the presence ofsignificant
obstructive CAD. Therefore, stress tests are only able
to detect CAD in the advanced stages of the athero-
sclerotic process. Detection ofcoronary calcifications
by EBCT, however, yields a much greater diagnostic
sensitivity when compared with noninvasive stress
testing due to detection ofCAD in the earlier stages
of the atherosclerotic process. Therefore, the
pathophysiology behind the atherosclerotic processes
favours the use ofEBCT as a first-line diagnostic tool
in the evaluation of suspected CAD.
The second question is whether detection ofCAD
in the early stages ofthe atherosclerotic process predicts
the occurrence of major adverse cardiac events and
should have consequences for the clinical management
in patients with suspected CAD. It has been shown
that traditional evaluation of low-risk patients with
suspected CAD without ST-segment changes or
elevated cardiac enzymes should be improved, since 5%
ofthese patients will experience a major adverse cardiac
event within two weeks after presentation.4 This
observation confirms the difficulty in risk stratification,
based on clinical variables, into patients with high,
intermediate and low risk of a future coronary event.
Although more obstructive CAD is associated with
even worse clinical outcome, the majority of acute
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coronary syndromes result from plaque ruptures or
erosions at locations with nonsignificant CAD.
Therefore, a diagnostic tool used to improve cardiac
risk stratification should not only prove the presence
of obstructive CAD, but should evaluate the total
atherosclerotic burden and thus the vulnerability for
plaque rupture. The detection ofcoronary calcifications
by EBCT fulfils this prerequisite. EBCT has a high
positive predictive value for the occurrence of major
adverse cardiac events in large patient groups.5-7
Therefore, in any patient with suspected CAD and
presence ofcoronary calcifications, coronary risk factors
should be evaluated and minimised and, if indicated,
use of aspirin and statins should be instituted.8 In the
clinical management ofpatients with suspected CAD,
EBCT therefore shows a major advantage when com-
pared with exercise tolerance testing.
EBCT, as currently used without radiographic
contrast agents, does not provide information on
obstructive CAD. However, increasing amounts of
calcifications are associated with obstructive CAD.3
Evidence of a large atherosclerotic burden and the
anatomical localisation ofcalcifications (left main stem!)
may identify potential candidates for a revascularisation
procedure. In patients presenting with typical anginal
complaints, one may question whether performance of
EBCT prior to coronary angiography is useftil, since
in these patients the pretest probability is very high
and may not be changed by the amount of coronary
calcifications (Bayes' theorem). However, the majority
of patients presenting to the emergency department
with suspected CAD do not have typical angina, but
show atypical or nonanginal complaints. In these
patients EBCT may be helpful in the risk stratification
prior to coronary angiography. It has been reported that
in Europe up to 50% or more ofcoronary angiographies
are not followed by a revascularisation procedure. This
observation raises questions about the use ofcoronary
angiography in patients with suspected CAD, since
this procedure is expensive and associated with a low
but significant risk of complications. Coronary
angiography is often performed to evaluate the
presence ofCAD in patients with a low likelihood of
CAD, but with an abnormal or nonconclusive exercise
tolerance test result. Exercise tolerance testing
frequently shows false-positive results, especially in
women and those with a low pretest likelihood of
CAD. If EBCT is used as a first-line diagnostic tool
prior to CAG, the performance of coronary angio-
graphy in patients with normal coronary arteries will
for a large part be prevented.
Furthermore, EBCT is very useful in patients with
suspected CAD because ofits high negative predictive
value.57 A considerable number of patients with
suspected but unproven CAD continue to have
symptoms and require resources resulting in increased
medical costs. The absence of coronary calcifications
virtually excludes the presence of clinically significant
CAD and the occurrence of major adverse cardiac
events in the future. Preliminary data on the EBCT
findings in patients with suspected CAD, but a
nondiagnostic ECG and negative cardiac markers in
the University Medical Centre ofGroningen, show that
over 50% ofpatients had a calcium score <10. During
three months of follow-up no coronary events or
revascularisation procedures occurred. These results
are promising, and need to be confirmed by longer
follow-up, in larger cohorts ofpatients.
We have brought up both pathophysiological and
clinical arguments that favour the use ofEBCT as a
first-line diagnostic tool in the evaluation ofsuspected
CAD. The remaining question is how EBCT should
be implemented in a clinical decision protocol for
patients with suspected CAD. We suggest first evalu-
ating the presence ofCAD by EBCT in all clinically
stable patients with suspected CAD. In the absence of
coronary calcifications, patients can be discharged
safely. When coronary calcifications are present,
evaluation of obstructive CAD should take place to
decide whether a patient should undergo coronary
angiography and a revascularisation procedure if
indicated. *
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